Migraine, Cluster, and Tension Headaches: Symptoms, Causes, and Treatment
Headache specialist Brian Grosberg breaks down the three most common headache types with Peter Attia: tension-type, migraine, and cluster. They cover how each is diagnosed without a biomarker, why migraine is a full neurologic disease, and the modern toolkit of lifestyle changes, preventive drugs like CGRP antibodies, and acute treatments.
Overview
Headache is one of the most common neurologic symptoms, yet it receives only a few hours of teaching across medical school and even neurology residency. In this conversation, headache neurologist Brian Grosberg walks Peter Attia through the field, starting with a crucial fact: there is no biomarker for headache, so diagnosis rests on a detailed history. He separates primary headaches, which are the disease itself, from secondary headaches caused by another condition, and then profiles the big three: tension-type, migraine, and cluster.
Migraine emerges as a full neurologic disease that can move through a premonitory phase, aura, the headache, and a hangover-like postdrome, affecting about 12% of people and three times as many women as men. The discussion explores genetics and hormones, why a rapid drop in estrogen drives menstrual migraine, and how triggers only provoke attacks in people who are biologically predisposed.
Cluster headache is described as one of the most painful conditions known, with distinctive one-sided pain and circadian timing. On treatment, Brian details modifiable risk factors like sleep, weight, and medication overuse, then the preventive and acute drug classes, from beta blockers and CGRP antibodies to triptans, Botox, and neuromodulation devices. The episode closes with the red-flag signs of secondary headache and a reminder that good care is a marathon, not a sprint.
Key quotes
5The list of things that can cause headache is probably one of the most extensive in all of medicine, with over 300 different types and causes.
Tension-type headache is everything that migraine isn't.
One patient likened cluster headache to giving birth to 100 babies at the same time without an epidural.
This is not Amazon Prime. Good things come to those who wait; we're building on incremental gains.
At the end of the day, it's a marathon, not a sprint.
Key ideas
9Headaches have no biomarker
Unlike a torn ligament on an MRI, no scan or blood test confirms a headache. Diagnosis rests on a detailed history that separates primary headaches, the disease itself, from secondary ones caused by another condition.
The big three and their criteria
Tension-type is mild to moderate, both-sided, with no nausea and only light or sound sensitivity. Migraine needs at least five lifetime attacks lasting 4 to 72 hours with specific features. Cluster is rarer but among the most painful.
Migraine is a neurologic disease with phases
Migraine is not just pain. It can move through a premonitory phase, aura in about a quarter to a third of people, the headache itself, and a hangover-like postdrome that can last days.
Prevalence and hidden burden
Migraine affects about 12% of people, roughly one billion worldwide and 45 million in the US, and strikes women three times as often. Its biggest economic cost is presenteeism: people at work but not at full capacity.
Episodic versus chronic migraine
Episodic migraine means fewer than 15 headache days a month; chronic migraine means 15 or more. About 1 to 2% of people live with chronic migraine, in headache more than half the time.
Genetics and hormones both matter
Migraine is polygenic and highly hereditary, and a rapid late-luteal drop in estrogen is uniquely linked to menstrual migraine. Hormonal milestones from puberty to menopause all shift the pattern.
Triggers are not causes
Triggers only provoke attacks in people who are biologically predisposed, and usually it takes two or more combined. A month-long headache diary is the single most useful tool to reveal patterns.
Cluster headache is distinct
Strictly one-sided pain around the eye peaks in 5 to 15 minutes, comes with a drooping lid, tearing, and restlessness, and follows circadian and seasonal rhythms tied to the hypothalamus.
The CGRP pathway changed treatment
Migraine is a neurovascular process involving the trigeminal nerve and the peptide CGRP. Blocking CGRP with monoclonal antibodies or oral gepants, plus triptans and Botox, has reshaped prevention and acute care.
Practical takeaways
6- 1
Keep a headache diary for a month 1:08:00
Track sleep, meals, caffeine, alcohol, menstrual timing, and attacks. A month-long log reveals the pattern and empowers both you and your clinician far more than any gadget.
- 2
Fix the modifiable risk factors 1:40:00
Address sleep apnea and insomnia, moderate alcohol, avoid medication overuse, and manage weight; morbid obesity raises migraine frequency up to fivefold. These changes also improve overall health.
- 3
Give preventive treatment time 1:52:00
Preventive medications can take weeks to months to work, and failing one drug in a class does not mean the next will not help. Patience and incremental gains are the goal, not an overnight cure.
- 4
Treat acute attacks early 33:00
Once allodynia sets in, roughly 30 to 60 minutes into an attack, triptans may work less well. Knowing your attack profile helps you treat at the right moment with the right formulation.
- 5
Know the red flags 2:04:00
New or changed headache patterns, fever or a stiff neck, unintended weight loss, neurologic symptoms, onset after 50, or a thunderclap peak all warrant prompt medical evaluation for secondary causes.
- 6
Treat headache holistically 1:38:00
Medication is only part of the plan. Regular sleep, routine meals, hydration, exercise, and stress reduction are a double win: better headaches and better long-term health.
Topics & chapters
14Welcome and Brian's path into headache medicine
How a prolonged migraine case during his first month of residency led Brian Grosberg, by serendipity, into the under-taught field of headache medicine.
A shared patient and a decade of collaboration
Peter and Brian trace their connection through a patient whose migraines were a central part of her life.
No biomarker: primary vs secondary headaches
Why headache has no confirming scan, and how clinicians separate primary headaches from those caused by another condition.
The big three and their diagnostic criteria
Tension-type, migraine, and cluster headaches defined, with the specific features that distinguish migraine from everything else.
Migraine phases: premonitory, aura, allodynia
The premonitory calm before the storm, visual aura and how to tell it from a stroke, and the sensitivity called allodynia.
Prevalence and societal burden
Migraine affects about 12% of people, three times more women than men, with a massive cost in lost and diminished work.
Episodic vs chronic migraine; specialist shortage
The spectrum from a few attacks a year to more than half the month, and how few headache specialists are trained each year.
Genetics and hormones; menstrual migraine
Why migraine runs in families and how estrogen's rapid decline drives menstrual migraine across the reproductive years.
Triggers vs causes and the headache diary
How triggers only act on the predisposed, and why a month-long diary is the most powerful diagnostic tool.
Perimenopause, menopause, and HRT
How migraine shifts through the menopausal transition and the delicate balance of using hormones without making it worse.
Cluster headache: the 'suicide headache'
The distinctive one-sided pain, autonomic signs, restlessness, and circadian and seasonal timing of cluster headache.
Modifiable lifestyle and risk factors
Sleep, obesity, alcohol, medication overuse, and an individualized, elimination-style approach to triggers.
Preventive and acute medications
Beta blockers, antidepressants, anti-epileptics, CGRP antibodies and gepants, Botox, triptans, and when each is used.
Neuromodulation, cannabis, and red-flag causes
External stimulation devices, what we do and don't know about cannabis, and the warning signs of secondary headache like CSF leaks.